These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8135177)
41. [Analysis and prognostic factors of the specimen of radical prostatectomy in prostate cancer]. Fromont G; Molinié V; Soulié M; Salomon L Prog Urol; 2015 Nov; 25(15):999-1009. PubMed ID: 26519964 [TBL] [Abstract][Full Text] [Related]
42. Handling of radical prostatectomy specimens: total or partial embedding? Vainer B; Toft BG; Olsen KE; Jacobsen GK; Marcussen N Histopathology; 2011 Jan; 58(2):211-6. PubMed ID: 21323948 [TBL] [Abstract][Full Text] [Related]
43. Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling. Filter ER; Gabril MY; Gomez JA; Wang PZT; Chin JL; Izawa J; Moussa M Int J Surg Pathol; 2017 Aug; 25(5):414-420. PubMed ID: 28381150 [TBL] [Abstract][Full Text] [Related]
44. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [TBL] [Abstract][Full Text] [Related]
45. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR; McNeal JE; Gill H; Presti JC Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152 [TBL] [Abstract][Full Text] [Related]
46. Development of a registration framework to validate MRI with histology for prostate focal therapy. Reynolds HM; Williams S; Zhang A; Chakravorty R; Rawlinson D; Ong CS; Esteva M; Mitchell C; Parameswaran B; Finnegan M; Liney G; Haworth A Med Phys; 2015 Dec; 42(12):7078-89. PubMed ID: 26632061 [TBL] [Abstract][Full Text] [Related]
48. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Kupelian P; Katcher J; Levin H; Zippe C; Klein E Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737 [TBL] [Abstract][Full Text] [Related]
49. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. Epstein JI; Walsh PC; Carmichael M; Brendler CB JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797 [TBL] [Abstract][Full Text] [Related]
50. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer? van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051 [TBL] [Abstract][Full Text] [Related]
51. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related]
52. Assessment of the circumferential margins, extraprostatic extension and Gleason score in radical prostatectomy specimens: Comparison of a partial embedding method with supplemental total inclusion of peripheral tissues. Fadul LC; da Silva MT; de Freitas LA; Athanazio DA Pathol Res Pract; 2016 Mar; 212(3):217-21. PubMed ID: 26774290 [TBL] [Abstract][Full Text] [Related]
53. Correlation of gross morphologic features with histologic features in radical prostatectomy specimens. Renshaw AA Am J Clin Pathol; 1998 Jul; 110(1):38-42. PubMed ID: 9661921 [TBL] [Abstract][Full Text] [Related]
54. The role of the pathologist in the evaluation of radical prostatectomy specimens. Ekici S; Ayhan A; Erkan I; Bakkaloğlu M; Ozen H Scand J Urol Nephrol; 2003; 37(5):387-91. PubMed ID: 14594686 [TBL] [Abstract][Full Text] [Related]
55. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296 [TBL] [Abstract][Full Text] [Related]
56. Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy. Ranaweera M; Samaratunga H; Duffy D; Klopfer K; Brunelli M; Martignoni G; Delahunt B Pathology; 2011 Dec; 43(7):693-6. PubMed ID: 22002115 [TBL] [Abstract][Full Text] [Related]
57. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. Hoedemaeker RF; Rietbergen JB; Kranse R; Schröder FH; van der Kwast TH J Urol; 2000 Aug; 164(2):411-5. PubMed ID: 10893598 [TBL] [Abstract][Full Text] [Related]
58. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF Cancer; 1997 Dec; 80(11):2109-19. PubMed ID: 9392333 [TBL] [Abstract][Full Text] [Related]
59. Use of digital maps and sampling of radical prostatectomy specimens. Trpkov K; Warman L Arch Pathol Lab Med; 2006 Dec; 130(12):1751-2; author reply 1752. PubMed ID: 17149939 [No Abstract] [Full Text] [Related]
60. Prostatectomy tissue for research: balancing patient care and discovery. Furman J; Murphy WM; Rice L; Drew PA; Narayan P Am J Clin Pathol; 1998 Jul; 110(1):4-9. PubMed ID: 9661916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]